KALA- Kala Bio, Inc.
Kala Bio, Inc. (KALA) has 7 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. KALA is classified in the Biotechnology industry within the Health Care sector.
Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 103.5K | $72.6K | - | |
| 10% | 46.5K | $32.6K | - | |
| Other | 41.8K | $29.3K | - | |
| Other | 36.0K | $25.2K | - | |
| Dir | 35.9K | $25.2K | - |
Activity
Buys and sells only
Transactions
10 filings · page 4
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 31, 2024 | Brazzell Romulus K72 | See Remarks | Sell | 2,002 | $6.09 | $12,192.18 | -2.2% | -12.4% | -44.6% | |
| May 31, 2024 | Iwicki Mark T72 | Chief Executive Officer | Sell | 7,392 | $6.09 | $45,017.28 | -2.6% | -12.4% | -44.6% | |
| Jan 4, 2024 | Trachtenberg Eric67 | See Remarks | Sell | 1,227 | $6.74 | $8,269.98 | -1.8% | +11.1% | +13.3% | |
| Jan 4, 2024 | Kharabi Darius59 | Chief Business Officer | Sell | 1,385 | $6.73 | $9,321.05 | -2.1% | +11.1% | +13.3% | |
| Jan 4, 2024 | Brazzell Romulus K72 | See Remarks | Sell | 1,617 | $6.74 | $10,898.58 | -1.7% | +11.1% | +13.3% | |
| Jan 4, 2024 | Iwicki Mark T72 | Chief Executive Officer | Sell | 4,539 | $6.73 | $30,547.47 | -1.6% | +11.1% | +13.3% | |
| Jan 4, 2024 | Reumuth Mary72 | Chief Financial Officer | Sell | 1,227 | $6.74 | $8,269.98 | -1.8% | +11.1% | +13.3% | |
| Jan 4, 2024 | Bazemore Todd73 | See Remarks | Sell | 1,405 | $6.74 | $9,469.70 | -100% | +11.1% | +13.3% | |
| Jan 4, 2023 | Reumuth Mary72 | Chief Financial Officer | Sell | 60 | $28.54 | $1,712.40 | -0.5% | -67.0% | -83.4% | |
| Jan 4, 2023 | Brazzell Romulus K72 | See Remarks | Sell | 73 | $28.53 | $2,082.69 | -0.4% | -67.0% | -83.4% |